Serge Jabbour, MD, FACP, FACE

Serge Jabbour, MD, FACP, FACE

Professor of Medicine
Thomas Jefferson University
Division of Endocrinology, Diabetes and Metabolic Diseases
Department of Medicine
Jefferson Medical College
Philadelphia, Pennsylvania

Related Videos

From a practical, titration perspective what important clinical guidance can you provide to optimize effectiveness of the fixed ratio insulin-GLP-1 RA combination? Video

From a practical, titration perspective what important clinical guidance can you provide to optimize effectiveness of the fixed ratio insulin-GLP-1 RA combination?

From a practical, titration perspective what important clinical guidance can you provide to optimize effectiveness of the fixed ratio insulin-GLP-1 RA combination?

What level of HA1c reduction is achieved with the fixed ratio combination and how is the side effect profile of the GLP-1 RA affected by the combination formulation and the titration strategy it utilizes? Video

What level of HA1c reduction is achieved with the fixed ratio combination and how is the side effect profile of the GLP-1 RA affected by the combination formulation and the titration strategy it utilizes?

What level of HA1c reduction is achieved with the fixed ratio combination and how is the side effect profile of the GLP-1 RA affected by the combination formulation and the titration strategy it utilizes?

How would you approach a 65-year old patient with T2D who has reasonable control of FBG but clear documentation of PPG? Video

How would you approach a 65-year old patient with T2D who has reasonable control of FBG but clear documentation of PPG?

How would you approach a 65-year old patient with T2D who has reasonable control of FBG but clear documentation of PPG?

How would approach a mildly obese patient with T2D on a maximum dose of metformin who is not yet achieving FPG or PPG target goals? Video

How would approach a mildly obese patient with T2D on a maximum dose of metformin who is not yet achieving FPG or PPG target goals?

How would approach a mildly obese patient with T2D on a maximum dose of metformin who is not yet achieving FPG or PPG target goals?

Can you identify the specific composition of fixed ratio combination long-acting insulin/GLPA-1 RA formulations, and how clinicians should titrate and deploy these agents? Video

Can you identify the specific composition of fixed ratio combination long-acting insulin/GLPA-1 RA formulations, and how clinicians should titrate and deploy these agents?

Can you identify the specific composition of fixed ratio combination long-acting insulin/GLPA-1 RA formulations, and how clinicians should titrate and deploy these agents?

What is the physiological, safety, efficacy and compliance-focused rationale for combining basal insulin plus GLP-1 RA into a fixed ratio formulation? How does this impact FPG and PPG control? Video

What is the physiological, safety, efficacy and compliance-focused rationale for combining basal insulin plus GLP-1 RA into a fixed ratio formulation? How does this impact FPG and PPG control?

What is the physiological, safety, efficacy and compliance-focused rationale for combining basal insulin plus GLP-1 RA into a fixed ratio formulation? How does this impact FPG and PPG control?

From a practical, titration perspective what important clinical guidance can you provide to optimize effectiveness of the fixed ratio insulin-GLP-1 RA combination? Video

From a practical, titration perspective what important clinical guidance can you provide to optimize effectiveness of the fixed ratio insulin-GLP-1 RA combination?

From a practical, titration perspective what important clinical guidance can you provide to optimize effectiveness of the fixed ratio insulin-GLP-1 RA combination?

What level of HA1c reduction is achieved with the fixed ratio combination and how is the side effect profile of the GLP-1 RA affected by the combination formulation and the titration strategy it utilizes? Video

What level of HA1c reduction is achieved with the fixed ratio combination and how is the side effect profile of the GLP-1 RA affected by the combination formulation and the titration strategy it utilizes?

What level of HA1c reduction is achieved with the fixed ratio combination and how is the side effect profile of the GLP-1 RA affected by the combination formulation and the titration strategy it utilizes?

How would you approach a 65-year old patient with T2D who has reasonable control of FBG but clear documentation of PPG? Video

How would you approach a 65-year old patient with T2D who has reasonable control of FBG but clear documentation of PPG?

How would you approach a 65-year old patient with T2D who has reasonable control of FBG but clear documentation of PPG?